These complex molecular mechanisms not only highlight the multiple effects of SGLT-2 inhibitors in renal protection but also provide new strategies and directions for the treatment of CKD, underscoring their importance in modern nephrology (48). This evidence concerns the gene SLC5A2 and chronic kidney disease.